4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-23-003073
Director sold 3,200 shares at $30.00 ($96,000)
- Director acquired 7,867 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Waddill William D. Director | 2023-01-09 | Sale | −3,200 | $30.00 | $96,000 | 28,950 | D |
| Waddill William D. Director | 2023-01-10 | Grant or award | +7,867 | 36,817 | D | ||
| Derivatives | |||||||
| Waddill William D. Director | 2023-01-10 | Grant or award · Common Stock | +4,593 | 4,593 | D | ||
| Open-market sales · 3,200 sh · avg $30.00 · $96,000 | |||||||
Loading xslF345X03/doc4.xml…